Latanoprost/Timolol Blumont (Timolol Maleate, Latanoprost)

Timolol Maleate is a non‑selective beta‑adrenergic blocker that reduces the production of aqueous humor by inhibiting beta receptors in the ciliary body epithelium. This decrease in fluid formation contributes to lower intraocular pressure.

The dosing regimen for Latanoprost/Timolol Blumont is determined by the prescribing clinician based on the patient’s condition, response, and tolerance. Typically, one drop is instilled into the affected eye(s) once daily, but the exact schedule must follow the prescriber’s instructions.

Safety data for Latanoprost/Timolol during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with single‑agent therapies, the combination of Latanoprost (a prostaglandin analog) and Timolol (a beta‑blocker) offers additive intraocular‑pressure reduction, often achieving greater efficacy with a single daily drop. This can improve adherence versus using two separate medications.

The product should be stored at room temperature, below 25 °C, in its original container. Protect it from light and moisture, and keep the cap tightly closed when not in use to maintain stability.

Latanoprost/Timolol is administered as an ophthalmic solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place one drop into the conjunctival sac of the prescribed eye(s). Close the eye gently for a few seconds and avoid touching the bottle tip to any surface.

Serious risks include severe allergic reactions, uveitis, corneal edema, and systemic beta‑blocker effects such as bradycardia, hypotension, or bronchospasm, especially in patients with pre‑existing respiratory or cardiac conditions. Any of these symptoms require immediate medical attention.

Patients with known hypersensitivity to timolol, latanoprost, or any excipients in the formulation should avoid this product. It is also contraindicated in individuals with severe asthma, chronic obstructive pulmonary disease, sinus bradycardia, or advanced heart block without appropriate medical supervision.